-
The Role of Confirmation Bias in Decision Making
Written by Abe Maingi, VP of Precision Medicine, Kineticos Confirmation bias is our tendency to search for and favor all -
Are we Manufacturing the right T-Cells And a Look at the Future of Oncology Precision Medicine
The final part of the discussion between Kineticos’ Operating Executive, Steve Buckanavage and Precision Biosciences’ CMO, Christopher Heery M.D., covers -
Is Precision Medicine in Oncology Narrowing Patient Population Too Much?
Kineticos’ Operating Executive Steve Buckanavage, continues his discussion with Christopher Heery, M.D., CMO at Precision Biosciences as they tackle the -
Can We Create Companion Diagnostics In Oncology With What We Know About Biomarkers?
As we continue our discussion between Steve Buckanavage, Kineticos’ Operating Executive and Christopher Heery, M.D., CMO at Precision Biosciences, we -
Are Checkpoint Inhibitors Impacting How We Cure Disease?
Throughout September and October, we have been discussing Precision Medicine and it’s impact on various segments of the life sciences. -
Is Precision Medicine Impacting Innovation in Pharma?
Shailesh and Alan finish their discussion with how there were speculation that precision medicine would reduce innovation in pharma. See
The Precision Medicine practice at Kineticos helps diagnostic companies— including labs and tools companies—maximize their commercial potential at the corporate and product levels while ensuring companies operate in an efficient manner.
The Precision Medicine practice at Kineticos supports clients across three service areas including:
Corporate Strategy and Development
- Market, Competitor, Customer Assessments
- Go-to-Market Strategy
- Mergers and Acquisitions
- Licensing and Acquisitions
Technology and Innovation
- Technology Assessment
- R&D Innovation Strategy
- Co-Development Models
Click the Tabs Below for Precision Medicine Practice Case Studies, White Papers and Articles, and Blog
-
Market Opportunity Assessment
Situation: An innovative preclinical CRO with multiple disruptive service offerings retained Kineticos to conduct an evaluation of each of their -
503B Compounding Pharmacy Market Assessment
Situation: A global biopharma company was interested in a comprehensive evaluation of the 503B compounding pharmacy market. The client was -
Primary Research Study
Kineticos conducted primary research via KOLs and an online survey to give our client qualitative and quantitative data to support -
Contract Development and Manufacturing Due Diligence
Challenge: An international private equity firm was looking at acquiring a Contract Development and Manufacturing Organization and needed to understand -
Go-to-Market Strategy and Tactical Deployment Plan
Situation: A privately held emerging biotech company, with an innovative cancer detection test, retained Kineticos to assist them in effectively -
Voice of Customer Study
Situation: A joint venture between two European companies was looking to maximize the commercial potential of its automated plate reader
-
How Metrics Can Help Identify and Solve Operational Challenges
Article Preview As the sophistication of operational practices across life sciences increases; unfortunately, so do the difficulty and complexity of -
Growth by Acquisition in Life Sciences: Do You Have a Plan?
Article Preview As the life sciences landscape continually changes, growth by acquisition has become increasingly common. Recent deals, such as -
Next Generation Sequencing: Using Technology to Develop Mutually-Beneficial Partnerships
Article Preview Arup Laboratories announced it will begin offering next-generation sequencing (NGS) based high resolution Human Leukocyte Antigen (HLA) genotyping -
Role of Companion Diagnostics in Immuno-oncology Race Unfolding
Article Preview Important oncology events, including ASCO and ESMO, have recently displayed the fruits of the huge investment drug companies -
Merck KGaA Announces Acquisition of Sigma-Aldrich, Increasing Lab Supply Division Growth
Article Preview Germany’s Merck KGaA has announced the acquisition of Sigma-Aldrich Corporation, a global life sciences tools (LST) firm, based -
Outsourcing as Opportunity
Article Preview An article published in FiercePharma discussed the top 10 largest pharma layoffs in 2013. Whenever layoffs are announced